Document is current
Any future updates will be listed below
-
Authors
Zhu, Yufu
Zhang, Xuefeng
Jin, Jiaqi
Wang, Xiaoqian
Liu, Yang
Gao, Jian
Hang, Diancheng
Fang, Lin
Zhang, Hengzhu
Liu, Hongmei
-
Funding
Funding for this research was provided by:
Scientific Research Project of Health Commission of Jiangsu Province (M2021062)
Xuzhou Medical Leading Talents Training Project (XWRCHT20210031)
Jiangsu Provincial Medical Key Discipline (ZDXK202228)
High-level Hospital Construction Project in Jiangsu Province (GSPJ202407)
Xuzhou Medical University Affiliated Hospital High-Level Scientific Research Project Cultivation Plan (2024104197)
Shenzhen Basic Research Project (JCYJ20220530114409020)
Science, Technology and Innovation Commission of Shenzhen Municipality (KJZD20230923114612025)
- License Information
-
More Information
Article History
Received: 25 October 2024
Accepted: 7 February 2025
First Online: 15 February 2025
Declarations
:
: All animal experiments were approved by the Ethics of Animal Committee of Xuzhou Medical University (approval number: 202402T002). All authors confirmed that the Ethics of Animal Committee of Xuzhou Medical University allowed the maximum tumor growth of mice to 10% of body weight after tumor implantationthe and that all mouse tumors did not exceed the maximal tumour burden. All experiments were carried out in accordance with Xuzhou Medical University Regulations on Animal Experimentation. Glioma specimens utilized in this study were derived from postoperative waste materials. The study has been approved by the Ethics Committee of the Affiliated Hospital of Xuzhou Medical University, with an exemption from patient informed consent, under the approval number XYFY2024-KL324-01.
: Not applicable.
: The authors declare no competing interests.
